Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Conway

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency VirusSahar Saeed, Erin Strumpf, Erica E M Moodie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infectionLinda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
International Journal of Epidemiology|September 30, 2009
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort studyMarina B Klein, Sahar Saeed, Hong Yang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2005
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study)Andrew R Zolopa, Laura C Lazzeroni, Alex Rinehart, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 11, 2023
Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta-analysisStephanie C Munari, Michael W Traeger, Vinay Menon, et al.
Journal of Viral Hepatitis|March 22, 2021
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World StudyMina S Farag, Scott Fung, Edward Tam, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BPatrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
The New England Journal of Medicine|August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIVSusan J Little, Sarah Holte, Jean-Pierre Routy, et al.
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency VirusSahar Saeed, Erin Strumpf, Erica E M Moodie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infectionLinda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
International Journal of Epidemiology|September 30, 2009
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort studyMarina B Klein, Sahar Saeed, Hong Yang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2005
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study)Andrew R Zolopa, Laura C Lazzeroni, Alex Rinehart, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 11, 2023
Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta-analysisStephanie C Munari, Michael W Traeger, Vinay Menon, et al.
Journal of Viral Hepatitis|March 22, 2021
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World StudyMina S Farag, Scott Fung, Edward Tam, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BPatrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
The New England Journal of Medicine|August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIVSusan J Little, Sarah Holte, Jean-Pierre Routy, et al.
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Pageof 15